Data Availability StatementThe data used to support the findings of this study are available from the corresponding author upon request. Herein, we chose osteosarcoma cell lines differed in metastatic potential, Sesamin (Fagarol) metastatic 143B and highly metastatic MG63.2 cells, in order to further investigate the anticancer mechanism of 2-methoxyestradiol. The current study aimed to determine the role of major heat shock proteins, Hsp90 and Hsp70 in 2-methoxyestradiol-induced osteosarcoma cell death. We focused on the implication of Hsp90 and Hsp70 in control under expression of neuronal nitric oxide synthase, localization of the enzyme, and further generation of nitro-oxidative stress. To give the insight into the role of Hsp90 in regulation of anticancer efficacy of 2-methoxyestradiol, we used geldanamycin Sesamin (Fagarol) as a potent Hsp90 inhibitor. Herein, we evidenced that inhibition of Sesamin (Fagarol) Hsp90 controls the protein expression of 2-methoxyestradiol-induced neuronal nitric oxide synthase and inhibits enzyme nuclear translocation. We propose that decreased level of neuronal nitric oxide synthase protein after a combined treatment with 2-methoxyestradiol and geldanamycin is directly associated with the accompanying upregulation of Hsp70 and downregulation of Hsp90. This interaction resulted in abrogation of anticancer efficacy of 2-methoxyestradiol by geldanamycin. < 0.01 versus control. Viability of 143B cells was significantly diminished from 81% to 31% (Figure 1A), whereas MG63.2 cells from 82% to 29% (Figure 1B) in the presence of series of dilutions of 2-ME (0.8 MC50 M) as compared to control, respectively. Survival of 143B was reduced from Sesamin (Fagarol) 77.28% to 23.1% (Figure 1A) while MG63.2 from 90.6% to 29.8% (Figure 1B) in the presence of series of dilutions of GA (0.8 MC50 M) as compared to control. Subsequently, 143B and MG63.2 cells were treated with combination of 2-ME and GA (concentrations range 0.8 MC50 M, molar ratio 1:1). The combined treatment with 2-ME and GA on both 143B and MG63.2 cells resulted in comparable anti-proliferative effects to compounds when used separately (Figure 1A,B, indicated as red color). Specifically, treatment of 143B cell line with 2-ME and GA in combination resulted in inhibition of cell proliferation from 58.3% to 21.4% (Figure 1A). While viability of MG63.2 was diminished from 68% to 29.2% (Figure 1B). Notably, as indicated by calculated EC50 values, MG63.2 cell line is approximately 10 times more resistant in comparison to 143B cell line. These results confirm high metastatic potential of MG63.2 cell line. Specifically, the EC50 values calculated for 2-ME and GA in OS 143B were equal to 0.42 M and 1.3 M, respectively; while in MG63.2 were equal to 4.21 M and 15.8 M, respectively. While, EC50 values calculated for combination of 2-ME and GA in 143B and MG63.2 cells were at the similar level as compared to separate treatment1.12 M and 15.1 M, respectively. 2.2. A Quantitative Measure of the Degree of Drug Interaction We have further quantitatively evaluated the degree of 2-ME and GA interaction in OS 143B cells as representative cell line using Calcusyn software [45]. Based on the results of MTT assay, we evaluated the median-effect plot, doseCeffect curve and Fa-CI plot (Figure 2). Open in a separate window Figure 2 Antagonistic effect between 2-ME and GA. Anti-proliferative potential of 2-ME (red line), GA (green line), and the combination of both compounds (blue line) was determined by MTT assay as described above. Consequently, median-effect plot (A), doseCeffect curve (B), and Fa-CI plot (C) were evaluated by CalcuSyn software. Values are the mean SE from three independent experiments. The calculated combination index (CI) for mixture of 2-MA and GA (molar ratio 1:1) at ED50, ED75 and ED90 was equal to 1.76165, 1.74029, 1.71927 (r = 0.98), respectively. CI more than 1 which clearly indicates antagonism between compounds. The calculated Dm Sesamin (Fagarol) value for combination of 2-ME and GA was equal to 6.05 10?6 (6.05e?6) while m was value Rabbit Polyclonal to Histone H3 more than 1.7 indicates the hyperbolic doseCeffect curve (Figure 2). 2.3. Antagonistic Effect of 2-ME and GA in Osteosarcoma Cell Death Model In order to further investigate the interaction between 2-ME and GA, we consequently investigated the impact of the compounds on induction of OS 143B and MG 63.2 cell death using flow cytometry. Based on the obtained anti-proliferative data and our previous studies [4,5,6,7,8], we chose the representative concentrations of 2-ME equaled to 1 1 M or 10 M; while of GA equaled to 2 M or 4 M for the following studies. To determine the influence of 24 h long treatment with either 2-ME (1 M or 10 M) or GA (2 M or 4 M), or a combination of both on induction of cell death in OS cells, flow cytometric-double staining (Annexin V and PI) was performed. As presented in Table 1, an increase in apoptotic and necrotic 143B and MG63.2 cell number resulted from 2-ME (1 M or 10 M) or GA (2 M or 4 M), treatment was observed. Next goal of the study was to determine the effect of.
Categories
- 11??-Hydroxysteroid Dehydrogenase
- 45
- 5-HT6 Receptors
- 7-TM Receptors
- 7-Transmembrane Receptors
- Acetylcholine Nicotinic Receptors, Non-selective
- Adrenergic ??1 Receptors
- Adrenergic Related Compounds
- AHR
- Aldosterone Receptors
- Androgen Receptors
- Antiprion
- AT2 Receptors
- ATPases/GTPases
- Atrial Natriuretic Peptide Receptors
- Calcineurin
- CAR
- Carboxypeptidase
- Casein Kinase 1
- Corticotropin-Releasing Factor
- CysLT1 Receptors
- Dardarin
- Deaminases
- Death Domain Receptor-Associated Adaptor Kinase
- Delta Opioid Receptors
- DMTs
- DNA-Dependent Protein Kinase
- Dual-Specificity Phosphatase
- Dynamin
- eNOS
- ER
- G Proteins (Small)
- GAL Receptors
- General
- GLT-1
- Glucagon and Related Receptors
- Glycine Receptors
- Growth Factor Receptors
- Growth Hormone Secretagog Receptor 1a
- GTPase
- Guanylyl Cyclase
- KDM
- Kinesin
- Lipid Metabolism
- Main
- MAPK
- MCH Receptors
- Muscarinic (M2) Receptors
- NaV Channels
- Neurotransmitter Transporters
- NFE2L2
- Nitric Oxide Precursors
- Nitric Oxide Signaling
- NPFF Receptors
- Opioid
- Other
- Other MAPK
- Other Peptide Receptors
- Other Transferases
- OX1 Receptors
- OX2 Receptors
- OXE Receptors
- PAO
- Phosphatases
- Phosphoinositide 3-Kinase
- Phosphorylases
- Pim Kinase
- Polymerases
- Purine Transporters
- Sec7
- Serine Protease
- Sodium/Calcium Exchanger
- Sphingosine Kinase
- V2 Receptors
-
Recent Posts
- [PubMed] [Google Scholar] 52
- Methods and Material 2
- It has been well established that harboring the allele enhances dementia associated with Alzheimers disease (AD), and several studies have supported a role of proteolysis as an important factor that may contribute to this risk [2,3C10]
- [PubMed] [Google Scholar]Xiao YF, Ke Q, Wang SY, Auktor K, Yang Con, Wang GK, Morgan JP, Leaf A
- Although passively-administered hyperimmune serum conferred protection in intact birds [15,17,18], the contribution of innate defenses and cell-mediated immunity to the control of APEC in the avian host remains ill-defined
Tags
- 68521-88-0
- a 105-120 kDa heavily O-glycosylated transmembrane glycoprotein expressed on hematopoietic progenitor cells
- Ankrd11
- Capn1
- Carboplatin cost
- DKFZp781B0869
- HA6116
- Hdac11
- IGF2R
- INK 128 supplier
- JTK4
- LRP2
- Masitinib manufacturer
- MDA1
- Mouse monoclonal to CD34.D34 reacts with CD34 molecule
- Mouse monoclonal to ERBB3
- Mouse monoclonal to INHA
- order NVP-AEW541
- PECAM1
- Rabbit Polyclonal to AML1
- Rabbit polyclonal to AML1.Core binding factor CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters.
- Rabbit Polyclonal to AQP12
- Rabbit Polyclonal to C-RAF phospho-Ser301)
- Rabbit Polyclonal to C-RAF phospho-Thr269)
- Rabbit polyclonal to CD80
- Rabbit Polyclonal to Claudin 3 phospho-Tyr219)
- Rabbit Polyclonal to CYSLTR1
- Rabbit polyclonal to DDX20
- Rabbit Polyclonal to EDG4
- Rabbit Polyclonal to FGFR2
- Rabbit Polyclonal to GAS1
- Rabbit Polyclonal to GRP94
- Rabbit polyclonal to INMT
- Rabbit Polyclonal to KAPCB
- Rabbit Polyclonal to MMP-2
- Rabbit Polyclonal to MT-ND5
- Rabbit Polyclonal to OR52E2
- Rabbit polyclonal to PHC2
- Rabbit Polyclonal to RAB31
- Rabbit Polyclonal to SLC25A31
- Rabbit Polyclonal to ZC3H13
- Rabbit polyclonal to ZNF268
- TNFRSF13C
- VAV1
- Vegfa